Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,018 | 8 | 81.6% |
| Travel and Lodging | $2,241 | 9 | 13.0% |
| Food and Beverage | $921.39 | 22 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14,384 | 21 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $2,643 | 11 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $124.51 | 6 | $0 (2018) |
| Illumina, Inc. | $28.50 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.50 | 1 | Illumina, Inc. ($28.50) |
| 2022 | $1,593 | 1 | Merck Sharp & Dohme LLC ($1,593) |
| 2021 | $975.00 | 1 | Merck Sharp & Dohme Corporation ($975.00) |
| 2020 | $1,950 | 2 | Merck Sharp & Dohme Corporation ($1,950) |
| 2019 | $9,866 | 17 | Merck Sharp & Dohme Corporation ($9,866) |
| 2018 | $2,767 | 17 | AstraZeneca Pharmaceuticals LP ($2,643) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Illumina, Inc. | Oncology Testing (Device) | Food and Beverage | Cash or cash equivalent | $28.50 | General |
| Category: Genetics | ||||||
| 09/07/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,592.50 | General |
| 06/18/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| 11/25/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| 09/25/2020 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| 11/25/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| 11/25/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 11/15/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $49.03 | General |
| 11/15/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $48.84 | General |
| 11/15/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $34.99 | General |
| 11/14/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $467.58 | General |
| 11/14/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $238.26 | General |
| 11/14/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $109.98 | General |
| 08/16/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 06/07/2019 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| 06/07/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 05/03/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $57.49 | General |
| 05/03/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 05/03/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 05/02/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $281.37 | General |
| 05/02/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $273.60 | General |
| 05/02/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 11/01/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $83.37 | General |
| 11/01/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| 11/01/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.21 | General |
About Gabriel Bien-Willner, M.D., PH.D
Gabriel Bien-Willner, M.D., PH.D is a Anatomic Pathology healthcare provider based in Oak Ridge North, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1154573251.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gabriel Bien-Willner, M.D., PH.D has received a total of $17,180 in payments from pharmaceutical and medical device companies, with $28.50 received in 2024. These payments were reported across 39 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($14,018).
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Molecular Genetic Pathology
- Location Oak Ridge North, TX
- Active Since 10/21/2008
- Last Updated 09/19/2022
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154573251
Products in Payments
- LYNPARZA (Drug) $2,549
- Oncology Testing (Device) $28.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.